1000+ types of tissue microarray

TISSUE ARRAYS

BR1006b	Breast cancer tissue array, including pathology grade, TNM and clinical stage, 50 cases/100 cores, replacing BR1006a
Cores	100	Cases	50
Row number	10	Column number	10
Core Diameter(mm)	1.0	Thickness(µm)	5.0
Tissue Array Type	FFPE	Species	Human
QA/QC	H&E and IHC confirmed
Applications	Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes	1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better. 2.Bake the slides for 60 minutes at 65℃ before the experiment. 3.Please choose a gentle repair method to avoid tissue detachment.

Legend:

Bre

-Breast

AT (*)

Benign (*)

Malignant (*)

Malignant (IA)

Malignant (IIA)

Malignant (IIB)

Malignant (IIIA)

Malignant (IIIB)

TISSUE ARRAYS BR1006b

	1	2	3	4	5	6	7	8	9	10
A	BRE	BRE	BRE	BRE	BRE	BRE	BRE	BRE	BRE	BRE
B	BRE	BRE	BRE	BRE	BRE	BRE	BRE	BRE	BRE	BRE
C	BRE	BRE	BRE	BRE	BRE	BRE	BRE	BRE	BRE	BRE
D	BRE	BRE	BRE	BRE	BRE	BRE	BRE	BRE	BRE	BRE
E	BRE	BRE	BRE	BRE	BRE	BRE	BRE	BRE	BRE	BRE
F	BRE	BRE	BRE	BRE	BRE	BRE	BRE	BRE	BRE	BRE
G	BRE	BRE	BRE	BRE	BRE	BRE	BRE	BRE	BRE	BRE
H	BRE	BRE	BRE	BRE	BRE	BRE	BRE	BRE	BRE	BRE
I	BRE	BRE	BRE	BRE	BRE	BRE	BRE	BRE	BRE	BRE
J	BRE	BRE	BRE	BRE	BRE	BRE	BRE	BRE	BRE	BRE

Pos	No	Age	Sex	Organ_Anatomic_Site	Pathology_diagnosis	Grade	TNM	Stage	Type
A1	1	39	F	Breast	Invasive carcinoma of no special type	2	T2N1M0	IIB	Malignant
A2	2	39	F	Breast	Invasive carcinoma of no special type	2	T2N1M0	IIB	Malignant
A3	3	38	F	Breast	Invasive carcinoma of no special type	2	T2N0M0	IIA	Malignant
A4	4	38	F	Breast	Invasive carcinoma of no special type	*	T2N0M0	IIA	Malignant
A5	5	53	F	Breast	Invasive carcinoma of no special type	2	T2N0M0	IIA	Malignant
A6	6	53	F	Breast	Invasive carcinoma of no special type	2	T2N0M0	IIA	Malignant
A7	7	41	F	Breast	Invasive carcinoma of no special type	3	T3N1M0	IIIA	Malignant
A8	8	41	F	Breast	Invasive carcinoma of no special type	3	T3N1M0	IIIA	Malignant
A9	9	55	F	Breast	Invasive carcinoma of no special type	3	T2N0M0	IIA	Malignant
A10	10	55	F	Breast	Invasive carcinoma of no special type	3	T2N0M0	IIA	Malignant
B1	11	60	F	Breast	Invasive carcinoma of no special type	3	T4N1M0	IIIB	Malignant
B2	12	60	F	Breast	Invasive carcinoma of no special type	3	T4N1M0	IIIB	Malignant
B3	13	52	F	Breast	Invasive carcinoma of no special type	3	T3N0M0	IIB	Malignant
B4	14	52	F	Breast	Invasive carcinoma of no special type	3	T3N0M0	IIB	Malignant
B5	15	68	F	Breast	Invasive carcinoma of no special type	3	T4bN0M0	IIIB	Malignant
B6	16	68	F	Breast	Invasive carcinoma of no special type	3	T4bN0M0	IIIB	Malignant
B7	17	46	F	Breast	Mucinous carcinoma	*	T2N0M0	IIA	Malignant
B8	18	46	F	Breast	Mucinous carcinoma	*	T2N0M0	IIA	Malignant
B9	19	66	F	Breast	Mucinous carcinoma	*	T3N0M0	IIB	Malignant
B10	20	66	F	Breast	Mucinous carcinoma	*	T3N0M0	IIB	Malignant
C1	21	47	F	Breast	Mucinous carcinoma	*	T2N0M0	IIA	Malignant
C2	22	47	F	Breast	Mucinous carcinoma	*	T2N0M0	IIA	Malignant
C3	23	65	F	Breast	Mucinous carcinoma	*	T2N0M0	IIA	Malignant
C4	24	65	F	Breast	Mucinous carcinoma	*	T2N0M0	IIA	Malignant
C5	25	52	F	Breast	Mucinous carcinoma	*	T1N0M0	IA	Malignant
C6	26	52	F	Breast	Mucinous carcinoma	*	T1N0M0	IA	Malignant
C7	27	41	F	Breast	Mucinous carcinoma	*	T2N0M0	IIA	Malignant
C8	28	41	F	Breast	Mucinous carcinoma	*	T2N0M0	IIA	Malignant
C9	29	40	F	Breast	Mucinous carcinoma	*	T3N0M0	IIB	Malignant
C10	30	40	F	Breast	Mucinous carcinoma	*	T3N0M0	IIB	Malignant
D1	31	45	F	Breast	Mucinous carcinoma	*	T2N0M0	IIA	Malignant
D2	32	45	F	Breast	Mucinous carcinoma	*	T2N0M0	IIA	Malignant
D3	33	60	F	Breast	Medullary carcinoma	*	T3N2M0	IIIA	Malignant
D4	34	60	F	Breast	Medullary carcinoma	*	T3N2M0	IIIA	Malignant
D5	35	47	F	Breast	Medullary carcinoma	*	T2N0M0	IIA	Malignant
D6	36	47	F	Breast	Medullary carcinoma	*	T2N0M0	IIA	Malignant
D7	37	51	F	Breast	Medullary carcinoma	*	T2N0M0	IIA	Malignant
D8	38	51	F	Breast	Medullary carcinoma	*	T2N0M0	IIA	Malignant
D9	39	55	F	Breast	Medullary carcinoma	*	T2N1M0	IIB	Malignant
D10	40	55	F	Breast	Medullary carcinoma	*	T2N1M0	IIB	Malignant
E1	41	42	F	Breast	Medullary carcinoma	*	T2N0M0	IIA	Malignant
E2	42	42	F	Breast	Medullary carcinoma	*	T2N0M0	IIA	Malignant
E3	43	35	F	Breast	Medullary carcinoma	*	T2N0M0	IIA	Malignant
E4	44	35	F	Breast	Medullary carcinoma	*	T2N0M0	IIA	Malignant
E5	45	51	F	Breast	Paget's disease	*	*	*	Malignant
E6	46	51	F	Breast	Paget's disease	*	*	*	Malignant
E7	47	47	F	Breast	Paget's disease	*	*	*	Malignant
E8	48	47	F	Breast	Paget's disease	*	*	*	Malignant
E9	49	51	F	Breast	Paget's disease	*	*	*	Malignant
E10	50	51	F	Breast	Paget's disease	*	*	*	Malignant
F1	51	82	F	Breast	Paget's disease	*	*	*	Malignant
F2	52	82	F	Breast	Paget's disease	*	*	*	Malignant
F3	53	87	F	Breast	Carcinosarcoma	*	*	*	Malignant
F4	54	87	F	Breast	Carcinosarcoma	*	*	*	Malignant
F5	55	56	F	Breast	Carcinosarcoma	*	*	*	Malignant
F6	56	56	F	Breast	Carcinosarcoma	*	*	*	Malignant
F7	57	33	F	Breast	Cystosarcoma phyllodes (low potential malignancy)	*	*	*	Malignant
F8	58	33	F	Breast	Cystosarcoma phyllodes (low potential malignancy)	*	*	*	Malignant
F9	59	48	F	Breast	Cystosarcoma phyllodes (low potential malignancy)	*	*	*	Malignant
F10	60	48	F	Breast	Cystosarcoma phyllodes (low potential malignancy)	*	*	*	Malignant
G1	61	40	F	Breast	Cystosarcoma phyllodes (low potential malignancy)	*	*	*	Malignant
G2	62	40	F	Breast	Cystosarcoma phyllodes (low potential malignancy)	*	*	*	Malignant
G3	63	32	F	Breast	Cystosarcoma phyllodes (low potential malignancy)	*	*	*	Malignant
G4	64	32	F	Breast	Cystosarcoma phyllodes (low potential malignancy)	*	*	*	Malignant
G5	65	37	F	Breast	Cystosarcoma phyllodes (moderate potential malignancy)	*	*	*	Malignant
G6	66	37	F	Breast	Cystosarcoma phyllodes (moderate potential malignancy)	*	*	*	Malignant
G7	67	69	F	Breast	Cystosarcoma phyllodes (moderate potential malignancy)	*	*	*	Malignant
G8	68	69	F	Breast	Cystosarcoma phyllodes (moderate potential malignancy)	*	*	*	Malignant
G9	69	40	F	Breast	Cystosarcoma phyllodes (high potential malignancy)	*	*	*	Malignant
G10	70	40	F	Breast	Cystosarcoma phyllodes (high potential malignancy)	*	*	*	Malignant
H1	71	40	F	Breast	Cystosarcoma phyllodes (high potential malignancy)	*	*	*	Malignant
H2	72	40	F	Breast	Cystosarcoma phyllodes (high potential malignancy)	*	*	*	Malignant
H3	73	15	F	Breast	Fibroadenoma	*	*	*	Benign
H4	74	15	F	Breast	Fibroadenoma	*	*	*	Benign
H5	75	23	F	Breast	Fibroadenoma	*	*	*	Benign
H6	76	23	F	Breast	Fibroadenoma	*	*	*	Benign
H7	77	17	F	Breast	Fibroadenoma	*	*	*	Benign
H8	78	17	F	Breast	Fibroadenoma	*	*	*	Benign
H9	79	32	F	Breast	Fibroadenoma	*	*	*	Benign
H10	80	32	F	Breast	Fibroadenoma	*	*	*	Benign
I1	81	19	F	Breast	Fibroadenoma	*	*	*	Benign
I2	82	19	F	Breast	Fibroadenoma	*	*	*	Benign
I3	83	16	F	Breast	Fibroadenoma	*	*	*	Benign
I4	84	16	F	Breast	Fibroadenoma	*	*	*	Benign
I5	85	46	F	Breast	Fibroadenoma	*	*	*	Benign
I6	86	46	F	Breast	Fibroadenoma	*	*	*	Benign
I7	87	46	F	Breast	Fibroadenoma	*	*	*	Benign
I8	88	46	F	Breast	Fibroadenoma	*	*	*	Benign
I9	89	42	F	Breast	Cancer adjacent breast tissue	*	*	*	AT
I10	90	42	F	Breast	Cancer adjacent breast tissue	*	*	*	AT
J1	91	50	F	Breast	Cancer adjacent breast tissue	*	*	*	AT
J2	92	50	F	Breast	Cancer adjacent breast tissue	*	*	*	AT
J3	93	42	F	Breast	Cancer adjacent breast tissue	*	*	*	AT
J4	94	42	F	Breast	Cancer adjacent breast tissue	*	*	*	AT
J5	95	56	F	Breast	Cancer adjacent breast tissue	*	*	*	AT
J6	96	56	F	Breast	Cancer adjacent breast tissue	*	*	*	AT
J7	97	38	F	Breast	Cancer adjacent breast tissue	*	*	*	AT
J8	98	38	F	Breast	Cancer adjacent breast tissue	*	*	*	AT
J9	99	39	F	Breast	Cancer adjacent breast tissue	*	*	*	AT
J10	100	39	F	Breast	Cancer adjacent breast tissue	*	*	*	AT
Tissue Marker